Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26815616 participants
OBSERVATIONAL
2023-04-11
2023-04-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clozapine-related Immunodeficiency in Parkinsons Disease
NCT06634641
CLOZAPINE Response in Biotype-1
NCT04580134
Study of the Effect of Dosing on Clozapine Levels
NCT02286206
Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder
NCT00683709
A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia
NCT00154258
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients presenting a possible drug-induced adverse effects
search for a clozapine intake
search for a clozapine intake
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
search for a clozapine intake
search for a clozapine intake
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adverse events reported were including the MedDRA terms: infections (SOC)
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Caen University Hospital, Department of Pharmacology
Caen, Normandy, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Clozinfection
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.